Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Medical device maker Theragenics Corp (TGX.N) said it had received a takeover offer of $69.9 million to $71.4 million from Juniper Investment Co, representing a premium of 51-54 percent to its closing stock price on Friday. The company’s shares rose about 36 percent to $2.03 in early trading on the Nasdaq. Juniper Investments is offering $2.25 to $2.30 per share in cash, Theragenics said. In a letter dated May 10, Juniper had offered Theragenics $2.05 to $2.10 per share. Theragenics said the latest offer represents a negotiated increase from the initial bid.
Help employers find you! Check out all the jobs and post your resume.
